Nika Pharmaceuticals, Inc (NIKA) stock
NIKAOTCPharmaceutical PreparationsFiscal year ends December 31
$0.41+0.00 (0.00%)
Close on Oct 16, 2026Market cap $431.19MP/E –Yield –
Nika Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Nika Pharmaceuticals's cash was $2.93K at Jun 30, 2026. For fiscal 2025 it was $1.89K, down 9.3% from the year before. The highest annual figure on record is $19.60K in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.89K | -9.3% |
| FY2024 | Dec 31, 2024 | $2.08K | -89.4% |
| FY2023 | Dec 31, 2023 | $19.60K | +2168.1% |
| FY2022 | Dec 31, 2022 | $864 | +116.5% |
| FY2021 | Dec 31, 2021 | $399 | -75.2% |
| FY2020 | Dec 31, 2020 | $1.61K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.93K | -81.2% |
| Q1 FY2026 | Mar 31, 2026 | $1.53K | -92.0% |
| Q4 FY2025 | Dec 31, 2025 | $1.89K | -9.3% |
| Q3 FY2025 | Sep 30, 2025 | $6.29K | +353.6% |
| Q2 FY2025 | Jun 30, 2025 | $15.62K | -20.3% |
| Q1 FY2025 | Mar 31, 2025 | $19.14K | -2.3% |
| Q4 FY2024 | Dec 31, 2024 | $2.08K | -80.9% |
| Q3 FY2024 | Sep 30, 2024 | $1.39K | -87.5% |
| Q1 FY2024 | Mar 31, 2024 | $19.60K | +339.5% |
| Q4 FY2023 | Dec 31, 2023 | $19.60K | +2168.1% |
| Q3 FY2023 | Sep 30, 2023 | $10.91K | +178.7% |
| Q2 FY2023 | Jun 30, 2023 | $11.05K | +29.4% |
| Q1 FY2023 | Mar 31, 2023 | $4.46K | +5272.3% |
| Q4 FY2022 | Dec 31, 2022 | $864 | +116.5% |
| Q3 FY2022 | Sep 30, 2022 | $3.91K | +130.4% |
| Q2 FY2022 | Jun 30, 2022 | $8.55K | +2047.0% |
| Q1 FY2022 | Mar 31, 2022 | $83 | -93.9% |
| Q4 FY2021 | Dec 31, 2021 | $399 | -75.2% |
| Q3 FY2021 | Sep 30, 2021 | $1.70K | – |
| Q2 FY2021 | Jun 30, 2021 | $398 | – |
| Q1 FY2021 | Mar 31, 2021 | $1.36K | – |
| Q4 FY2020 | Dec 31, 2020 | $1.61K | – |
See a number that looks wrong?